Most of the studies reporting that FOXP3+ TILs are an indicator of poor prognosis in breast cancer applied unstratified survival analyses [17],[19] and might be expected to largely reflect the majority ER + population, possibly confounded by an opposite association in ER– cases. This evidence concerns the gene FOXP3 and breast carcinoma.